Corticosteroids and corticotrophin in the treatment of Crohn's disease.
作者信息
Jones J H, Lennard-Jones J E
出版信息
Gut. 1966 Apr;7(2):181-7. doi: 10.1136/gut.7.2.181.
Abstract
摘要
相似文献
1
Corticosteroids and corticotrophin in the treatment of Crohn's disease.皮质类固醇和促肾上腺皮质激素治疗克罗恩病
Gut. 1966 Apr;7(2):181-7. doi: 10.1136/gut.7.2.181.
2
Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis).克罗恩病（局限性肠炎）的皮质类固醇或促肾上腺皮质激素疗法
Gut. 1970 Nov;11(11):921-7. doi: 10.1136/gut.11.11.921.
3
Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double-blind study and follow-up.静脉注射促肾上腺皮质激素与氢化可的松治疗克罗恩病住院患者的疗效比较：一项随机双盲研究及随访
Inflamm Bowel Dis. 1998 Aug;4(3):177-81. doi: 10.1097/00054725-199808000-00001.
4
[Comparative studies on the effects of ACTH, cortisone, prednisone, and prednisolone on tuberculin allergy].
Minerva Pediatr. 1956 Oct 20;8(42):1257-61.
5
[PHARMACODYNAMICS OF ADRENAL HORMONES FROM A CLINICAL VIEWPOINT].
Dtsch Med J. 1964 Nov 5;15:707-12.
6
[Crohn's disease: review of the acquisitions and problems of etiopathogenesis, histogenesis and therapy].[克罗恩病：病因发病机制、组织发生及治疗方面的研究进展与问题综述]
Clin Ter. 1981 Aug 15;98(3):309-25.
7
The drug therapy of ulcerative colitis and of Crohn's disease.
Semin Drug Treat. 1974 Spring;3(4):339-49.
8
Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.口服布地奈德在活动性克罗恩病中的疗效与口服泼尼松龙相当。全球布地奈德研究小组。
Gut. 1997 Aug;41(2):209-14. doi: 10.1136/gut.41.2.209.
9
Crohn's disease of the mouth.口腔克罗恩病
Am J Dig Dis. 1974 Apr;19(4):385-8. doi: 10.1007/BF01072531.
10
A long-term study of sarcoid and its modification by steroid therapy. Lung function and other factors in prognosis.结节病及其激素治疗效果的长期研究。肺功能及预后的其他因素。
Am J Med. 1966 Oct;41(4):528-40. doi: 10.1016/0002-9343(66)90215-4.
引用本文的文献
1
Chronic steroid use: An overlooked impact on patients with inflammatory bowel disease.长期使用类固醇：对炎症性肠病患者的一种被忽视的影响。
JGH Open. 2022 Nov 10;6(12):910-914. doi: 10.1002/jgh3.12841. eCollection 2022 Dec.
2
Steroid use and misuse: a key performance indicator in the management of IBD.类固醇的使用与滥用：炎症性肠病管理中的一项关键绩效指标。
Frontline Gastroenterol. 2020 Apr 2;12(3):207-213. doi: 10.1136/flgastro-2019-101288. eCollection 2021.
3
Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases.新旧生物制剂和小分子药物在炎症性肠病治疗中的定位。
World J Gastroenterol. 2018 Aug 28;24(32):3567-3582. doi: 10.3748/wjg.v24.i32.3567.
4
Fistulizing Crohn's Disease.瘘管性克罗恩病
Clin Transl Gastroenterol. 2017 Jul 13;8(7):e106. doi: 10.1038/ctg.2017.33.
5
The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.硬币的两面：肠易激疾病瘘管和狭窄形成的发病机制的异同。
United European Gastroenterol J. 2016 Aug;4(4):506-14. doi: 10.1177/2050640616635957. Epub 2016 Feb 19.
6
Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.克罗恩病：演变、表观遗传学以及微生物群靶向疗法的新作用
Curr Gastroenterol Rep. 2016 Mar;18(3):13. doi: 10.1007/s11894-016-0487-z.
7
Steroid use in Crohn's disease.在克罗恩病中的类固醇使用。
Drugs. 2014 Mar;74(3):313-24. doi: 10.1007/s40265-014-0183-y.
8
Enteral nutrition in Crohn's disease: an underused therapy.克罗恩病的肠内营养：一种未得到充分利用的治疗方法。
Gastroenterol Res Pract. 2013;2013:482108. doi: 10.1155/2013/482108. Epub 2013 Dec 5.
9
Diagnosis and management of fistulizing Crohn's disease.瘘管性克罗恩病的诊断与管理
Nat Clin Pract Gastroenterol Hepatol. 2009 Feb;6(2):92-106. doi: 10.1038/ncpgasthep1340. Epub 2009 Jan 20.
10
Anti-TNF strategies in stenosing and fistulizing Crohn's disease.狭窄性和瘘管性克罗恩病的抗肿瘤坏死因子策略
Int J Colorectal Dis. 2005 Jan;20(1):1-8. doi: 10.1007/s00384-004-0634-0. Epub 2004 Sep 30.
本文引用的文献
1
ILEO-CAECAL TUBERCULOSIS.回盲部结核
Gut. 1964 Dec;5(6):524-9. doi: 10.1136/gut.5.6.524.
2
ILEO-CAECAL GRANULOMATA.回盲部肉芽肿
Gut. 1964 Dec;5(6):517-23. doi: 10.1136/gut.5.6.517.
3
CROHN'S DISEASE OF THE LARGE INTESTINE.大肠克罗恩病
Gut. 1964 Dec;5(6):493-509. doi: 10.1136/gut.5.6.493.
4
CROHN'S DISEASE.克罗恩病
J R Coll Surg Edinb. 1964 Jan;10:115-27.
Zotero 插件